FDA inspection
Scinopharm Taiwan, Ltd.: FDA inspection ending Jun 23, 2026
FDA inspection 1326554 · Official Action Indicated (OAI) · Tainan City
Key facts
| Inspection ID | 1326554 |
|---|---|
| Firm | Scinopharm Taiwan, Ltd. |
| FEI number | 3002840477 |
| City | Tainan City |
| Country | Taiwan |
| Fiscal year | 2026 |
| Inspection end date | Jun 23, 2026 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data